Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility

Pfizer confirms all its colleagues are safe following a tornado that damaged predominantly the warehouse portion of its manufacturing facility in Rocky M...

July 24, 2023 | Monday | News
Integrated Biosciences Unveils Synthetic Biology Platform for Aging-Associated Stress Response Control

Optogenetic platform will be combined with AI at Integrated Biosciences to identify candidate anti-aging drugs Scientists demonstrate that cells make an i...

July 20, 2023 | Thursday | News
HUTCHMED's Fruquintinib Combo Receives Breakthrough Designation in China for Advanced Endometrial Cancer, Enrollment Complete

It is a multi-center, open-label clinical study to evaluate the efficacy and safety of fruquintinib in combination with sintilimab. Entry criteria include ...

July 20, 2023 | Thursday | News
AES Clean Technology achieves LEED certification for its cleanroom architectural system

LEED is a globally recognized symbol of sustainability achievement and leadership, and is a key milestone for AES, enabling it to meet increased customer d...

July 20, 2023 | Thursday | News
Neumora Therapeutics Begins Phase 3 Program for NMRA-140 in Major Depressive Disorder

Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the planned init...

July 19, 2023 | Wednesday | News
HNL Lab Medicine Announces Groundbreaking Digital Pathology Investment

The initiative combines Proscia’s innovative digital pathology software platform Concentriq Dx and Leica Biosystems’ scanner hardware. Proscia&...

July 19, 2023 | Wednesday | News
Capital Rx Launches Rx Reverse in Partnership with Virta Health to Combat Type 2 Diabetes and Obesity

 Capital Rx, the health technology company changing the way prescription drugs are priced and patients are cared for, and type 2 diabetes (T2D) r...

July 18, 2023 | Tuesday | News
Endo and Premier, Inc. Collaborate to Address Pitocin® (oxytocin injection, USP) Shortage

Endo International plc (OTC: ENDPQ) and Premier, Inc. (NASDAQ: PINC) announced today that Endo's Par Sterile Products business will supply Pitocin® (ox...

July 18, 2023 | Tuesday | News
Modi Ventures Launches $32M Fund to Disrupt Health and Medicine Tech

Modi Ventures, a newly launched venture partnership investing in fund managers and founders building companies shaping the future of humanity, today announ...

July 17, 2023 | Monday | News
Thermo Fisher Introduces Diomni Enterprise Software for Molecular Diagnostics

To address challenges with error-prone, manual molecular testing workflows, Thermo Fisher Scientific today has introduced Diomni Enterprise Software, helpi...

July 17, 2023 | Monday | News
Asep Inc.'s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample

Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce the results of a recent sc...

July 17, 2023 | Monday | News
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat...

July 17, 2023 | Monday | News
Lilly Acquires Versanis to Enhance Cardiometabolic Disease Care

Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab...

July 17, 2023 | Monday | News
GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US

GSK plc (LSE/NYSE: GSK) today announced it has started shipping doses of its quadrivalent influenza vaccines to US healthcare providers and pharmacies in p...

July 14, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close